Princeton, NJ, United States of America

Josh Chandy Mathew

This inventor holds 1 USPTO granted patent. Top assignee: Slayback Pharma LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Josh Chandy Mathew. Retrieved from https://idiyas.com/inventor/josh-chandy-mathew

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Josh Chandy Mathew in Liquid Pharmaceutical Compositions

Introduction

Josh Chandy Mathew, an innovative inventor based in Princeton, NJ, has made significant contributions to the field of pharmaceuticals. With a keen focus on liquid formulations, his work aims to enhance patient care through effective medication delivery.

Latest Patents

Josh holds a patent for "Liquid pharmaceutical compositions of baclofen for oral administration." This invention explores stable liquid pharmaceutical compositions of baclofen or its pharmaceutically acceptable salts. More specifically, it details formulations that maintain stability at concentrations of 5 mg/mL or more, making it suitable for oral administration. The compositions are designed to remain stable within pH ranges of 5-8 across various storage conditions, including extended long-term storage.

Career Highlights

Currently, Josh contributes his expertise as an inventor at Slayback Pharma LLC. His professional experience showcases not only his talent for innovation but also his commitment to improving medication accessibility and effectiveness. His work is crucial in developing liquid formulations that can lead to better patient compliance and outcomes.

Collaborations

Working alongside talented professionals such as Sushant Omprakash Dube and Girish Kumar Jain, Josh fosters a collaborative environment focused on advancing pharmaceutical sciences. Their combined efforts emphasize the importance of teamwork in achieving significant breakthroughs in drug formulation and delivery systems.

Conclusion

Josh Chandy Mathew's dedication to innovation in liquid pharmaceutical compositions illustrates the potential to improve patient treatment options. His contributions at Slayback Pharma LLC reflect a commitment to excellence in the realms of pharmaceuticals, promising a brighter future for medication delivery innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…